Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EOLS | US
-0.80
-4.67%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
16.34
17.05
17.18
16.31
Evolus Inc. a performance beauty company provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus Inc. was incorporated in 2012 and is headquartered in Newport Beach California.
View LessStrong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
53.9%1 month
55.5%3 months
50.1%6 months
44.9%-
106.38
52.11
6.56
0.54
-21.50
4.38
-
-24.64M
1.03B
1.03B
-
-9.11
-
35.60
-861.68
8.26
7.90
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.87
Range1M
3.18
Range3M
6.95
Rel. volume
0.76
Price X volume
8.07M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.49 | 1.03B | -1.97% | n/a | 19.31% |
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 30.87 | 923.02M | 0.13% | 83.11 | 178.54% |
Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 21.31 | 863.13M | -2.07% | 367.83 | 204.74% |
Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 16.515 | 761.79M | 6.34% | 10.85 | 73.76% |
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 4.3 | 693.71M | 0.94% | 50.25 | -199.01% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 17.9 | 506.39M | -4.48% | n/a | 0.00% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 4.42 | 495.19M | 0.00% | n/a | 117.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.95 | 450.75M | 3.34% | n/a | -329.45% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.3933 | 420.15M | -6.31% | 19.50 | 0.00% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 3.08 | 408.33M | 8.07% | n/a | 42.12% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Interface Inc | TILE | Textile Manufacturing | 18.13 | 1.06B | -0.28% | 16.28 | 106.26% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -21.50 | 17.21 | Cheaper |
Ent. to Revenue | 4.38 | 334.38 | Cheaper |
PE Ratio | - | 26.92 | - |
Price to Book | 52.11 | 12.15 | Expensive |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 50.06 | 68.34 | Lower Risk |
Debt to Equity | 6.56 | -1.00 | Expensive |
Debt to Assets | 0.54 | 0.48 | Par |
Market Cap | 1.03B | 5.31B | Emerging |